Hatchtech receives FDA special protocol agreement of DeOvo™ phase III studies and strengthens patent portfolio

You may also like

28 October 2019

Immunology Company Kira Biotech launches with $20M Series A Funding

16 March 2020

OneVentures invests in international software company Phocas, bringing business back to Australia and positioning the company for international expansion

06 November 2019

iStaySafe Acquires Find-Me Technologies, Strengthens position in the IoT Industry

27 November 2012

Hatchtech publish data on Head Lice treatment safety study and mechanism of action

26 October 2010

Hatchtech raises $6.3m for DeOvo™ Head Lice Phase 2b Clinical Trial

02 May 2013

NICTA’s ‘Incoming’ mobile video start-up company switches on with $1.1M in seed financing

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor